Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs.
Dragon Sail Pharmaceutical Co., Ltd. is a high-tech enterprise focusing on antibody drug CDMO services, and it is dedicated to providing one-stop services for partners from sequence to IND, clinical sample production to BLA and commercial production of antibody drugs. Dragon Sail Pharmaceutical has built the first cross-free antibody plant in China in Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, with a total investment of nearly RMB 700 million and a production scale of up to 12,000L. The site complies with Chinese, American and European GMP standards, and its unique NONCROS? cross-free antibody production platform complies with requirements for co-linear production of multiple products, featuring high overall operational efficiency and cost-effectiveness. Leveraging its integrated biopharmaceutical technology platform, Dragon Sail will accelerate the process of discovery, development and production of biological drugs especially for antibody drugs, empowering partners and benefiting patients.
